Cite
HARVARD Citation
Ghazanfar, M. et al. (2022). Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study. Clinical & experimental allergy. 52 (5), pp. 715-718. [Online].